Examkin

Soru

Zorluk: OrtaPharmacologic Interventions

A 64-year-old man presents to the clinic with a 3-day history of productive cough, fever, and progressive shortness of breath. He has a history of persistent atrial fibrillation, heart failure with preserved ejection fraction, and major depressive disorder. His home medications include sotalol, apixaban, escitalopram, and lisinopril. His temperature is 38.2°C (100.8°F), blood pressure is 130/80 mm Hg, heart rate is 72/min, and respiratory rate is 20/min. Oxygen saturation is 94% on room air. Physical examination reveals bronchial breath sounds and crackles over the right lower lung field. A chest radiograph demonstrates a right lower lobe consolidation. The patient is diagnosed with community-acquired pneumonia, and a decision is made to manage him in the outpatient setting. Which of the following is the most appropriate empiric antibiotic regimen for this patient?

  1. Amoxicillin-clavulanate and doxycyclineCevap
  2. B
    Levofloxacin
  3. C
    Amoxicillin
  4. D
    Amoxicillin-clavulanate and azithromycin
  5. E
    Ciprofloxacin

Cevap

Amoxicillin-clavulanate and doxycycline
The correct answer is amoxicillin-clavulanate and doxycycline. This patient has community-acquired pneumonia (CAP) and a history of heart failure, categorizing him as a patient with a major comorbidity. Current clinical guidelines recommend empiric outpatient treatment with either respiratory fluoroquinolone monotherapy (e.g., levofloxacin, moxifloxacin) OR combination therapy with a beta-lactam (e.g., amoxicillin-clavulanate, cefpodoxime) plus a macrolide (e.g., azithromycin) or doxycycline. However, this patient is already taking sotalol and escitalopram, both of which are strongly associated with QT interval prolongation. Adding a macrolide or a fluoroquinolone would create a dangerous cumulative risk for significant QT prolongation and subsequent Torsades de pointes. Doxycycline does not prolong the QT interval. Therefore, the combination of amoxicillin-clavulanate and doxycycline provides the necessary broad antimicrobial coverage while safely avoiding life-threatening pharmacodynamic drug interactions.

Adım Adım Çözüm

1
Diagnose the condition and identify the appropriate treatment category.
The patient has community-acquired pneumonia (CAP) with a major comorbidity (heart failure), which requires empiric combination therapy (a beta-lactam plus a macrolide or doxycycline) or respiratory fluoroquinolone monotherapy.
Comorbidities increase the risk of infection with beta-lactamase-producing organisms and atypical pathogens, necessitating broader antimicrobial coverage.
2
Review the patient's current medication list for potential drug interactions or contraindications.
The patient is taking sotalol (a Class III antiarrhythmic) and escitalopram (an SSRI), both of which are known to cause dose-dependent QT interval prolongation.
Identifying existing medications that prolong the QT interval is critical before prescribing new antimicrobial agents that might have additive arrhythmogenic effects.
3
Select the antimicrobial regimen that provides appropriate coverage while avoiding additive adverse effects.
Amoxicillin-clavulanate combined with doxycycline is selected because doxycycline does not prolong the QT interval, unlike macrolides (e.g., azithromycin) and fluoroquinolones (e.g., levofloxacin).
Combining multiple QT-prolonging drugs significantly increases the risk of life-threatening polymorphic ventricular tachycardia (Torsades de pointes).

Anahtar Kavram

In patients with community-acquired pneumonia and significant comorbidities, appropriate empiric therapy includes a beta-lactam plus either a macrolide or doxycycline. When a patient is concurrently taking QT-prolonging medications, doxycycline is preferred over macrolides or fluoroquinolones to avoid the risk of Torsades de pointes.
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru